Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy. Cazzaniga G, Mori M, Griego A, Scarpa E, et al. J Med Chem 2025 Mar 3. doi: 10.1021/acs.jmedchem.4c02386.

Read + Share

Amedeo Smart

Independent Medical Education

Cazzaniga G, Mori M, Griego A, Scarpa E, et al. Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy. J Med Chem 2025 Mar 3. doi: 10.1021/acs.jmedchem.4c02386.
PMID: 40029993